US permits use of anti-viral vaccine Remdesivir

The US food and drug regulatory body has allowed emergency use of an investigational anti-viral vaccine to treat COVID-19 patients after some researches, including one led by an Indian-American physician, found that the drug helped recover some of the infected cases faster.

The Food and Drug Administration gave emergency use authorization for the use of investigational anti-viral Remdesivir in the treatment of COVID-19 patients.

The FDA authorisation came after researches, including one led by Indian-American physician Aruna Subramanian, reported Remdesivir shortened the recovery times in people who have fallen ill from the new coronavirus.

"I'm pleased to announce that Gilead now has an emergency use authorization from the FDA for Remdesivir," US President Donald Trump told reporters at the White House on Friday.

Trump said that EUA is an important treatment for hospitalized coronavirus patients.

Health and Human Services Secretary Alex Azar said that this is a significant step forward in battling COVID-19.

Post a Comment

Previous Post Next Post